AMRN / Why Amarin Stock Tumbled This Week

Amarin's (AMRN) third-quarter 2023 earnings and revenues beat estimates. Vascepa sales in the United States decline year over year. more_horizontal

Amarin Corporation plc (NASDAQ:AMRN ) Cantor Fitzgerald Annual Global Healthcare Conference September 26, 2023 9:55 AM ET CompanyParticipants Patrick more_horizontal

Engaging in the world of low-cost stocks often referred to as penny stocks, is appealing to those looking to capitalize on the potential upsides of th more_horizontal

Amarin (AMRN) decides to initiate a restructuring plan to maximize cash flow opportunities in the United States. It also reports preliminary product r more_horizontal

Amarin recently acquired a completely revamped management. There seems to be no radical shift in strategy, however. Therefore, there is no radical cha more_horizontal

Start Time: 17:40 January 1, 0000 6:14 PM ET Amarin Corporation plc (NASDAQ:AMRN ) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 202 more_horizontal

Amarin's (AMRN) first-quarter 2023 earnings and revenues beat estimates. Vascepa sales decline. more_horizontal

Sarissa Capital has taken full control of Amarin. The previous management was doing some slow but decent work, but did not get time to show results. more_horizontal